The William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 (Public Law 116-283) Section 750goes to Congress.gov, mandated a “Study on the Incidence of Cancer Diagnosis and Mortality among Military Aviators and Aviation Support Personnel,” to examine the rate of cancer diagnosis and mortality among military fixed wing aviators (aircrew) and aviation support personnel (ground crew). The Defense Health Agency Armed Forces Health Surveillance Division conducted this study between July of 2021 and April of 2022.
Key Findings
The Phase 1 study explored cancer rates and mortality for all cancers and 12 site-specific cancers selected by high-interest veteran advocacy groups or prior studies that demonstrated increased rates in military populations. The site-specific cancers were:
- Colon and rectum
- Pancreatic
- Melanoma
- Prostate
- Testicular
- Urinary bladder
- Kidney and renal pelvis
- Brain and nervous system
- Thyroid
- Non-Hodgkin’s lymphoma
- Female breast
- Lung and bronchus
This study is the first time that all site-specific cancers were evaluated in a large population of military ground crew personnel.
The finding that aircrew members had higher melanoma and prostate cancer rates is similar to findings from previous studies. However, the finding of a higher rate of thyroid cancer hasn't been previously described.
- The finding of lower mortality rates in aircrew and ground crew compared to the U.S. population is similar to the findings of other similar studies.
- The military study population was relatively young compared to the U.S. population, and military service members generally have better access to health care including cancer screening services. The findings may have differed if additional, older, former service members had been included in the study since cancer risk and mortality rates increase with age.
Frequently Asked Questions
Q4:
Why is a second study necessary?
A:
The Phase 2 study is required to investigate and identify the specific occupational and environmental risk factors associated with the increased risk of the cancers identified in the Phase 1 study.
Q5:
What were the results of the Phase 1 study?
A:
Compared to the U.S. population, aircrew had a:
- 87% higher rate of melanoma,
- 39% higher rate of thyroid cancer,
- 16% higher rate of prostate cancer, and a
- 24% higher rate of cancer for all sites combined.
Ground crew members had higher rates of:
- Cancers of brain and nervous system (by 19%),
- Thyroid cancer (by 15%),
- Melanoma (by 9%),
- Kidney and renal pelvis cancer (by 9%), and
- Cancer of all sites combined (by 3%).
Rates of other site-specific cancers were either similar to or less than the U.S. population.
Q7:
Is there a link between military occupations and cancer?
A:
The current data isn't sufficient to determine a link between military occupations and cancer. The Phase 1-a study showed higher rates of cancer diagnoses in military aviators and ground support personnel than in the U.S. population when matched for age, race, and sex. However, these findings can't determine whether military occupations and cancers are linked. The purpose of the Phase 2 study will look at military occupational exposures and cancers.
Q8:
Did the study include members of the National Guard and Reserve?
A:
Phase 1-a of the study didn't include these groups. However, by obtaining data from the Department of Veterans Affairs Central Cancer Registry (VACCR) and 46 state cancer registries, Phase 1-b will capture National Guard and Reserve service members.
Q12:
When will the second study begin and end
A:
We anticipate delivery of findings of the second part of the Phase 1 study at the end of 2023. This second part of Phase 1 (referred to as Phase 1-b) will examine the rates of cancer diagnoses in Reserve and National Guard aviators and ground crew. The second study will begin shortly after, and an end date has not been set.
You also may be interested in...